The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
基本信息
- 批准号:10529326
- 负责人:
- 金额:$ 53.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AmericanAmino AcidsAmphetamine AbuseAmphetaminesAnimal ModelBIN1 geneBehaviorBehavioralBehavioral AssayBiochemistryBiological ModelsBrainCell membraneCessation of lifeCytoplasmDataDiseaseDistalDopamineDrosophila genusElectrophysiology (science)ElementsEventFamily memberGeographyGroomingHospitalizationHumanImpairmentLocomotionMeasuresMediatingMembrane ProteinsMethamphetamineMississippiModificationMolecularMolecular ConformationMotivationNeuronsOutcomePharmaceutical PreparationsPharmacotherapyPhasePhosphorylationPhosphotransferasesPost-Translational Protein ProcessingProcessPropertyRegulationReportingRewardsRoleSNAP receptorStimulantSystemTestingTranslatingUnited StatesUnited States Substance Abuse and Mental Health Services Administrationabuse liabilityamphetamine usebehavioral phenotypingbehavioral studybiophysical analysisdopamine transporterdopaminergic neuronextracellularflymolecular targeted therapiesneuropsychiatric disorderneurotransmissionopioid epidemicpreferencepsychostimulantreceptorstimulant abusesyntaxin 1
项目摘要
Project Summary/Abstract: Amphetamines (AMPHs) are psychostimulants commonly used for the
treatment of neuropsychiatric disorders. They are also abused, with devastating outcomes. The abuse potential
of AMPHs has been associated with their ability to cause mobilization of cytoplasmic dopamine (DA), leading to
an increase in extracellular DA levels. This increase is mediated, at least in part, by the reversal of the DA
transporter (DAT) function, which causes non-vesicular DA release (DA efflux). This DA efflux is thought to be
essential for the psychomotor stimulant properties of AMPHs, a notion supported by evidence that specific
inhibition of DA efflux impairs the ability of AMPH to cause locomotor behaviors. To date, no pharmacotherapies
are available for the treatment of AMPHs abuse. Therefore, it is essential to understand: a) the molecular
mechanisms targeted by AMPH to promote DA efflux; b) whether DA efflux disrupts DA functions in brain, and
whether these disruptions support AMPH-induced behaviors; and c) how we can target these mechanisms to
impair DA efflux to regulate AMPH behaviors.
Previously, using a combination of biochemistry, electrophysiology, as well as behavioral assays, we and
others have shown that the DAT N-Terminus (NT) is a critical structural domain for the ability of AMPH to promote
specific behaviors. This is because AMPH stimulates DAT NT phosphorylation, which is vital for its ability to
cause DA efflux. Furthermore, we provided the first evidence that the human DAT (hDAT) NT engages in direct
associations with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein, syntaxin 1
(Stx1), and that this interaction, in addition to hDAT phosphorylation, regulates AMPH-induced DA efflux and
behaviors. This was the first demonstration that the interaction of a plasma membrane protein with Stx1 is
essential for psychostimulant behaviors. Noteworthy is that our data suggest that the strength of this interaction
is regulated by AMPH-induced phosphorylation of Stx1.
We hypothesize that the functional and behavioral role of the hDAT NT phosphorylation is dictated by its
interactions with the plasma membrane protein, Stx1, a process regulated by the phosphorylation status of Stx1.
We propose to test this hypothesis through the following specific aims: 1) to determine how hDAT interacts
with Stx1; 2) to determine the involvement of Stx1 in AMPH-induced DA efflux. The molecular discoveries of
S.A. #1 and S.A. #2 will be evaluated in neurons, in isolated Drosophila brains, and behaviorally, by using
Drosophila as an animal model to study AMPH actions. We are now able to “humanize” flies by expressing hDAT
in DA neurons of Drosophila lacking the endogenous DAT (KO). In this system, we have established that AMPH-
associated behaviors, such as locomotion and grooming, are DAT-dependent. Also, in this animal model, we
can now determine preference (reward) and avoidance for AMPH. Thus, specific aim 3) is to determine whether
hDAT NT-Stx1 interactions are required for AMPH-induced behaviors.
项目摘要/摘要:安非他命(AMPHs)是一种常用的精神兴奋剂
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AURELIO GALLI其他文献
AURELIO GALLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AURELIO GALLI', 18)}}的其他基金
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
10402705 - 财政年份:2021
- 资助金额:
$ 53.17万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
9601228 - 财政年份:2017
- 资助金额:
$ 53.17万 - 项目类别:
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
10527164 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
GLP-1 Receptors and Psychostimulant Addiction
GLP-1 受体和精神兴奋剂成瘾
- 批准号:
8840923 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
8808750 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
9755714 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
9903264 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
The dopamine transporter's lipid interactions: understanding transporter function
多巴胺转运蛋白的脂质相互作用:了解转运蛋白的功能
- 批准号:
10545756 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
9330133 - 财政年份:2014
- 资助金额:
$ 53.17万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 53.17万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 53.17万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 53.17万 - 项目类别:














{{item.name}}会员




